About Senzime

Company Description

Senzime is a Swedish medical device company that develops, manufactures, and markets CE- and FDA-cleared patient monitoring systems. Senzime’s employees worldwide are committed to the vision of a world without anesthesia- and respiratory-related complications.

The company markets an innovative portfolio of solutions including the TetraGraph® and ExSpiron® 2Xi, for real-time monitoring of neuromuscular and respiratory functions, typically under and after surgery. The goal is to help eliminate in-hospital complications, and radically reduce health care costs related to surgical and high acuity procedures.

Year founded

1999

Served area

Worldwide

Headquarters

Ulls väg 41, 75651 Uppsala – Sweden

Shareholder information

Shares outstanding

69,883,985

IPO

April 11, 2017

Stock exchange(s)

Nasdaq Stockholm

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.